Jefferies Group reiterated their hold rating on shares of Clorox (NYSE:CLX) in a research note published on Wednesday morning. The brokerage currently has a $130.00 price objective on the stock.
CLX has been the topic of several other reports. Deutsche Bank assumed coverage on shares of Clorox in a report on Wednesday. They issued a hold rating and a $142.00 price objective on the stock. Royal Bank of Canada reissued a hold rating and set a $115.00 price target on shares of Clorox in a report on Sunday, October 8th. BMO Capital Markets reissued an outperform rating on shares of Clorox in a report on Tuesday, September 12th. Wells Fargo & Company reissued a hold rating and set a $130.00 price target on shares of Clorox in a report on Wednesday. Finally, Consumer Edge raised shares of Clorox from a neutral rating to an outperform rating in a report on Friday, November 10th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus target price of $129.05.
Shares of Clorox (NYSE:CLX) opened at $147.63 on Wednesday. The company has a market cap of $19,037.84, a price-to-earnings ratio of 26.60, a PEG ratio of 4.02 and a beta of 0.43. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02. Clorox has a twelve month low of $117.94 and a twelve month high of $148.23.
Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.41 by $0.05. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.48 billion. Clorox had a net margin of 11.84% and a return on equity of 161.59%. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.36 EPS. sell-side analysts predict that Clorox will post 5.6 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s dividend payout ratio (DPR) is presently 61.88%.
In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the transaction, the senior vice president now directly owns 34,867 shares in the company, valued at $4,742,260.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the transaction, the senior vice president now owns 10,896 shares of the company’s stock, valued at $1,421,492.16. The disclosure for this sale can be found here. Corporate insiders own 1.00% of the company’s stock.
A number of large investors have recently bought and sold shares of CLX. Advisor Partners LLC raised its position in Clorox by 12.4% during the second quarter. Advisor Partners LLC now owns 3,086 shares of the company’s stock worth $411,000 after acquiring an additional 341 shares during the period. Financial Advisory Service Inc. raised its position in Clorox by 0.3% during the second quarter. Financial Advisory Service Inc. now owns 4,012 shares of the company’s stock worth $535,000 after acquiring an additional 12 shares during the period. Trexquant Investment LP raised its position in Clorox by 33.3% during the second quarter. Trexquant Investment LP now owns 3,200 shares of the company’s stock worth $426,000 after acquiring an additional 800 shares during the period. Canada Pension Plan Investment Board raised its position in Clorox by 386.1% during the second quarter. Canada Pension Plan Investment Board now owns 78,795 shares of the company’s stock worth $10,499,000 after acquiring an additional 62,585 shares during the period. Finally, Carnick & Kubik Group LLC raised its position in Clorox by 13.2% during the second quarter. Carnick & Kubik Group LLC now owns 9,789 shares of the company’s stock worth $1,304,000 after acquiring an additional 1,143 shares during the period. Institutional investors own 73.42% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2017/12/17/clorox-clx-stock-rating-reaffirmed-by-jefferies-group.html.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.